| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/19/1999 | EP0916675A2 Process for preparing sildenafil |
| 05/19/1999 | EP0916670A2 Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists |
| 05/19/1999 | EP0915908A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 05/19/1999 | EP0915876A1 Tricyclic benzazepine vasopressin antagonists |
| 05/19/1999 | EP0915850A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
| 05/19/1999 | EP0915848A1 1,2-diarylindole as cox-2 inhibitors |
| 05/19/1999 | EP0915704A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/19/1999 | CN1216922A Porcine reproductive and respiratory syndrome vaccine |
| 05/19/1999 | CN1216762A 2-(arylphenyl) amino-imidazoline derivatives |
| 05/18/1999 | US5905084 5-HTIF -agonists effective in treating migraine |
| 05/18/1999 | US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide |
| 05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
| 05/14/1999 | WO1999023230A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | WO1999022714A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | WO1999013862A3 A pharmaceutical composition for treating dysmenorrhea and premature labor |
| 05/14/1999 | WO1999011282A9 Compositions and methods for contraception in or sterilization of mammals |
| 05/14/1999 | WO1997035539A3 Arylamino fused pyridines and pyrimidines |
| 05/14/1999 | CA2309165A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | CA2308029A1 Reagents and methods useful for detecting diseases of the breast |
| 05/12/1999 | EP0914165A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | CN1216537A Compounds with growth hormone releasing properties |
| 05/12/1999 | CN1216531A Indole derivatives useful as endothelin receptor antagonists |
| 05/12/1999 | CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 05/11/1999 | US5902830 Lowering plasma cholesterol levels |
| 05/11/1999 | US5902810 Pteridine derivatives as no synthase inhibitors |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine |
| 05/06/1999 | WO1999021562A1 Treatment of female sexual dysfunction |
| 05/06/1999 | WO1999021558A2 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 05/06/1999 | WO1999021557A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | WO1999021553A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | WO1999021508A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 05/06/1999 | WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides |
| 05/06/1999 | EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 05/06/1999 | EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912186A1 Progestogen-anti-progestogen regimens |
| 05/06/1999 | EP0785792B1 Treatment of ovarian estrogen dependent conditions |
| 05/06/1999 | CA2308454A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2308069A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2305293A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 05/06/1999 | CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/04/1999 | US5900432 Therapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanamides |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 04/29/1999 | WO1999020621A1 ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| 04/29/1999 | WO1999020608A1 Isoquinolines as urokinase inhibitors |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020282A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | WO1999020266A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 04/29/1999 | WO1999007740A3 Lipocalin homologs |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | CA2649671A1 Progestin therapy for causing endometrial atrophy while maintaining amenorrhea |
| 04/29/1999 | CA2307615A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | CA2307114A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0911028A2 Method for treating sexual dysfunction |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910565A1 Amide derivatives as selective neuropeptide y receptor antagonists |
| 04/28/1999 | EP0910398A1 Method of stimulating cilia |
| 04/28/1999 | EP0910377A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 04/28/1999 | EP0910369A1 Benzothiophenes, formulations containing same, and methods |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215404A Non-dendritic backbone piptide carrier |
| 04/28/1999 | CN1215396A Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215333A Use of derivativ |
| 04/28/1999 | CN1043140C Hydroxymethyl furazane carboxylic acid derivatives and its preparation process and medicinal composition |
| 04/27/1999 | US5897539 Hormone replacement therapy method and hormone dispenser |
| 04/27/1999 | CA2163778C Indole derivatives as steroid 5a-reductase inhibitors |
| 04/27/1999 | CA2122246C Phospholipid antimicrobial compositions |
| 04/22/1999 | WO1999019483A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | WO1999019479A1 Murine model for human carcinoma |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999019293A1 Novel aryloxy-alkyl-dialkylamines |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018942A1 Use of csaidtm compounds for the management of uterine contractions |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1998058957A3 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/22/1999 | CA2316296A1 Use of csaidtm compounds for the management of uterine contractions |
| 04/22/1999 | CA2307929A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |